FENO-guided asthma treatment during pregnancy fails to improve infant developmental outcomes suggests study

FENO-guided asthma treatment during pregnancy fails to improve infant developmental outcomes suggests a study published in the European Journal of Pediatrics.
Asthma during pregnancy is associated with a range of adverse perinatal outcomes. It is also linked to increased rates of neurodevelopmental conditions in the offspring. We aimed to assess whether fractional exhaled nitric oxide (FENO)-based asthma management during pregnancy improves child developmental and behavioural outcomes compared to usual care. The Breathing for Life Trial was a randomised controlled trial that compared FENO-based asthma management during pregnancy to usual care. Participants were invited to the developmental follow-up, the Breathing for Life Trial – Infant Development study, which followed up infants at 6 weeks, 6 months and 12 months. The primary outcomes were measured in infants at 12 months using the Bayley-III: Cognitive, Language and Motor composite scores. Secondary outcomes included Bayley-III social-emotional and adaptive behaviour scores, autism likelihood and sensory and temperament outcomes. The exposure of interest was the randomised intervention group. Two hundred and twenty-two infants and their 217 participating mothers were recruited to the follow-up; 107 mothers were in the intervention group and 113 were in the control group. There was no evidence of an intervention effect for the primary outcomes: Bayley-III cognitive (mean = 108.9 control, 108.5 intervention, p = 0.93), language (mean = 95.9 control, 95.6 intervention, p = 0.87) and motor composite scores (mean = 97.2 control, 97.9 intervention, p = 0.25). Mean scores for secondary outcomes were also similar among infants born to control and FENO group mothers, with few results reaching p < 0.05. In this sample, FENO-guided asthma treatment during pregnancy did not improve infant developmental outcomes in the first year of life.
Reference:
Whalen, Olivia M., et al. “Effect of Fractional Exhaled Nitric Oxide (FENO)-based Asthma Management During Pregnancy Versus Usual Care On Infant Development, Temperament, Sensory Function and Autism Signs.” European Journal of Pediatrics, 2024.
Keywords:
FENO-guided, asthma, treatment, pregnancy fails, improve, infant, developmental, outcomes, study, European Journal of Pediatrics, Whalen, Olivia M.